- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Alembic Pharmaceuticals Limited — Updates, 28-07-2026: Press Release
28-07-2026 | 01:26 pm
28-07-2026 | 01:26 pm
Alembic Pharma received USFDA final approval for Prucalopride Tablets, for chronic constipation. The drug targets an estimated market of ~₹830 Cr, providing a significant new opportunity.
No comments yet. Be the first to comment!